1996
Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
Wetherill PE, Landry ML, Alcabes P, Friedland G. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1996, 12: 33-7. PMID: 8624758, DOI: 10.1097/00042560-199605010-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAntibodies, MonoclonalAntigens, ViralCross-Sectional StudiesCytomegalovirusCytomegalovirus InfectionsCytomegalovirus RetinitisFemaleFluorescent Antibody TechniqueHIV SeropositivityHIV-1HumansLeukocytesMaleMiddle AgedPredictive Value of TestsRetrospective StudiesViral Matrix ProteinsViremiaConceptsCMV antigenemia testCMV diseaseAntigenemia testCMV antigenemiaHIV diseaseCytomegalovirus antigenemia testPositive CMV antigenemiaLife-threatening infectionsDiagnostic techniquesAntigenemia levelsAntigenemia resultsCMV retinitisCytomegalovirus infectionCMV cultureClinical evidenceOphthalmologic examPatientsDiseaseRapid diagnosisAntigenemiaInfectionDiagnosisQuantitative diagnostic techniqueRetinitisHIV
1982
Inverted ratio of inducer to suppressor T-lymphocyte subsets in drug abusers with opportunistic infections
Moll B, Emeson E, Small C, Friedland G, Klein R, Spigland I. Inverted ratio of inducer to suppressor T-lymphocyte subsets in drug abusers with opportunistic infections. Clinical Immunology 1982, 25: 417-423. PMID: 6218947, DOI: 10.1016/0090-1229(82)90206-9.Peer-Reviewed Original ResearchConceptsT lymphocyte subsetsOpportunistic infectionsOnly opportunistic infectionPercentage of T8Pneumocystis carinii pneumoniaPercentage of T4Ratio of inducerCutaneous anergyCarinii pneumoniaImmune statusPeripheral bloodOral candidiasisProliferative responsePatientsDrug abusersDrug abuseMarked reductionInfectionP. cariniiLymphocytesFurther evidencePneumoniaAnergyHistoplasmosisCandidiasis